Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 8,000
Avg Vol 1,024
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 96%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 33 26 83 83
Address:
Philip Heymans Alle 3, Hellerup, Denmark
Latest News on BVNKF
No data available.